Company intelligence / Profile preview

Orion Nutraceuticals

Vancouver, British Columbia, Canada

Ownership: Private
Development stage: Other

Overview

Orion Nutraceuticals is a Canadian life sciences company that focuses on the development and commercialization of plant-based health and wellness products, particularly within the sports medicine sector. The company aims to provide alternative therapies for pain management and recovery using hemp-derived compounds such as cannabidiol (CBD). In addition to product development, Orion pursues a strategy of strategic investments and acquisitions within the broader pharmaceutical and biotech industries, notably holding a significant equity stake in Medicure Inc. The company is headquartered in Vancouver and is publicly traded on the Canadian Securities Exchange under the symbol ORI.

Therapeutic areas: ImmunologyNeurologyOther
Modalities: Small molecule
Industry: Biotech

Partnerships

Medicure

Beyond the preview

Go deeper on Orion Nutraceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Orion Nutraceuticals.

Explore the full profile